China SXT Pharmaceuticals Net Debt Growth & History (SXTC)

China SXT Pharmaceuticals's net debt was −$27.1M for fiscal 2026.

View full China SXT Pharmaceuticals company overview

China SXT Pharmaceuticals annual net debt history

China SXT Pharmaceuticals annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20262026-03-31−$27.1M−$9.9M
20252025-03-31−$17.1M−$5.9M
20242024-03-31−$11.2M$5.6M
20232023-03-31−$16.8M−$4.0M
20222022-03-31−$12.7M$570,140
20212021-03-31−$13.3M−$6.1M
20202020-03-31−$7.2M$2.0M
20192019-03-31−$9.2M

China SXT Pharmaceuticals net debt trends

Over the last five fiscal years, China SXT Pharmaceuticals's net debt decreased from −$13.3M to −$27.1M, a change of −$13.8M. The latest reported quarter, Q4 2026, shows −$27.1M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review China SXT Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about SXTC yet. Start the conversation.

Write the first post